Asadi A, Pourfathollah A A, Mahdavi M, Eftekharian M M, Moazzeni S M
Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Hum Antibodies. 2008;17(3-4):73-8.
Monoclonal antibody against horseradish peroxidase (HRP) has many applications which peroxidase anti-peroxidase. Peroxidase-antiperoxidase (PAP) complex formation is its most known and important usage. This complex is used in many immunohistochemical and immunocytochemical staining techniques.
The aim of this study was the preparation of anti-HRP monoclonal antibody through hybridoma technology.
The BALB/c mice were immunized by repeated injections of HRP. After the confirmation of their immunization by ELISA test, the spleen lymphocytes and SP2/0 myeloma cells were hybridized using PEG as fusing agent. The hybridoma cells were then selected by culturing in HAT medium. Identification and selection of anti-HRP producing clones were done by ELISA test on culture supernatants of the obtained clones. To acquire the monoclones, limiting dilution was performed twice and the effect of finally obtained antibodies on enzyme activity was investigated by a specific ELISA test. In vivo tumor induction method was used for production of concentrated antibody. At last class and subclass of the obtained antibodies were determined by Isostrip Kit.
After seven rounds of cell fusions, 224 clones were obtained, from which, six ones were anti-HRP producers. Two clones (P1F11 and P2F6) with higher antibody secretion were selected and subcloned. Both derived hybridoma monoclones (P1F11D2 and P2F6F3) were producing antibodies from IgG1 subclass with kappa (Kappa) light chains which didn't affect the enzyme activity. The electrophoresis of ascetic fluid of tumor induced mice showed an obvious band in gamma (gamma) position.
The obtained monoclonal antibodies are from IgG class and don't affect the enzyme activity, therefore it seems that they are suitable for PAP complex production.
抗辣根过氧化物酶(HRP)单克隆抗体有许多应用,优于过氧化物酶抗过氧化物酶法。过氧化物酶抗过氧化物酶(PAP)复合物的形成是其最知名且重要的用途。该复合物用于许多免疫组织化学和免疫细胞化学染色技术。
本研究旨在通过杂交瘤技术制备抗HRP单克隆抗体。
通过反复注射HRP免疫BALB/c小鼠。经ELISA试验确认免疫后,以聚乙二醇(PEG)为融合剂将脾淋巴细胞与SP2/0骨髓瘤细胞进行杂交。然后在HAT培养基中培养筛选杂交瘤细胞。通过对所得克隆的培养上清液进行ELISA试验,鉴定并筛选产生抗HRP的克隆。为获得单克隆,进行两次有限稀释,并通过特异性ELISA试验研究最终获得的抗体对酶活性的影响。采用体内诱瘤法制备浓缩抗体。最后用Isostrip试剂盒测定所得抗体的类别和亚类。
经过七轮细胞融合,获得224个克隆,其中6个为抗HRP产生克隆。选择两个抗体分泌较高的克隆(P1F11和P2F6)进行亚克隆。两个衍生的杂交瘤单克隆(P1F11D2和P2F6F3)均产生IgG1亚类且带有κ(kappa)轻链的抗体,这些抗体不影响酶活性。诱瘤小鼠腹水的电泳在γ(gamma)位置显示出明显条带。
所得单克隆抗体属于IgG类,不影响酶活性,因此似乎适合用于制备PAP复合物。